Do T lymphocytes correlate danger signals to antigen?

Medical Hypotheses

Volumn 62, Issue 6, 2004, Pages 898-906

  Forden, Chris ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN FUNCTION; ANTIGEN SPECIFICITY; CANCER CELL; CANCER IMMUNOTHERAPY; CELL COMMUNICATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CELL TRANSFORMATION; CELLULAR IMMUNITY; CORRELATION ANALYSIS; CYTOTOXICITY; CYTOTOXICITY TEST; DENDRITIC CELL; HOST CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; THYMUS;

EID: 2542497965     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2003.12.029     Document Type: Article

References (33)

1. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
2. Medzhitov R, Janeway C. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296:300.
3. Matzinger P. Essay 1: the danger model in its historical context. Scand J Immunol 2001;54:4-9.
4. Kagi D, Seiler P, Pavlovic J, et al. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 1995;25:3256-62.
5. Lambot M, Douart A, Joris E, Letesson JJ, Pastoret PP. Characterization of the immune response of cattle against non-cytopathic and cytopathic biotypes of bovine viral diarrhoea virus. J Gen Virol 1997;78:1041-7.
6. Huber SA. T cells expressing the gamma delta T cell receptor induce apoptosis in cardiac myocytes. Cardiovasc Res 2000;45:579-87.
7. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 1990;87:9620-4.
8. Sieg S, Huang Y, Kaplan D. Viral regulation of CD95 expression and apoptosis in T lymphocytes. J Immunol 1997;159:1192-9.
9. Smyth MJ, Krasovskis E, Johnstone RW. Fas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8+ cytotoxic T lymphocytes. J Virol 1998;72:5948-54.
10. Burgert HG, Blusch JH. Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses. Virus Genes 2000;21:13-25.
11. Fahnestock ML, Johnson JL, Feldman RM, Neveu JM, Lane WS, Bjorkman PJ. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 1995;3:583-90.
12. Smyth MJ. Fas ligand-mediated bystander lysis of syngeneic cells in response to an allogeneic stimulus. J Immunol 1997;158:5765-72.
13. Suzuki I, Fink PJ. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med 1998;187:123-8.
14. Suzuki I, Martin S, Boursalian TE, Beers C, Fink PJ. Fas ligand costimulates the in vivo proliferation of CD8+ T cells. J Immunol 2000;165:5537-43.
15. Clarke P, Meintzer SM, Spalding AC, Johnson GL, Tyler KL. Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection. Oncogene 2001;20:6910-9.
16. Chou A-H, Tsai H-F, Lin L-L, Hsieh S-L, Hsu P-I, Hsu P-N. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol 2001;167:1347-52.
17. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8 alpha, beta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001;2:255-60.
18. Fuchs EJ, Matzinger P. Is cancer dangerous to the immune system? Semin Immunol 1996;8:271-80.
19. Janeway CA. A trip through my life with an immunological theme. Ann Rev Immunol 2002;20:1-28.
20. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 1997;276:2057-62.
21. Goldrath AW, Bevan MJ. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 1999;11:183-90.
22. Duke RC. Self-recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J Exp Med 1989;170:59-71.
23. Kojima H, Eshima K, Takayama H, Sitkovsky M. Leukocyte function-associated antigen-1-dependent lysis of Fas1 (CD951/Apo-11) innocent bystanders by antigen-specific CD8+ CTL. J Immunol 1997;159:2728-34.
24. Cosman D, Fanger N, Borges L. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers. Immunol Rev 1999;168:177-85.
25. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science 1992;258:1156-9.
26. Noessner E, Gastpar R, Milani V, Brandl A, Hutzler PJ, Kuppner MC. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J Immunol 2002;169:5424-32.
27. Cella M, Dohring C, Samaridis J, et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 1997;185:1743-51.
28. Sotomayor EM, Borrello I, Tubb E, Allison JP, Levitsky HI. In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. Proc Natl Acad Sci USA 1999;96:11, 476-81.
29. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-8.
30. Wagsater D, Dimberg J, Hugander A, Sirsjo A, Ghaderi M. Analysis of MICA gene transcripts in human rectal cancers. Anticancer Res 2003;23:2525-9.
31. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc Nat Acad Sci USA 1999;96:6879-84.
32. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002;419:679-80.
33. Kirn DH, McCormick F. Replicating viruses as selective cancer therapeutics. Mol Med Today 1996;2:519-27.